166 related articles for article (PubMed ID: 33180866)
1. Ikaros antagonizes DNA binding by STAT5 in pre-B cells.
Heizmann B; Le Gras S; Simand C; Marchal P; Chan S; Kastner P
PLoS One; 2020; 15(11):e0242211. PubMed ID: 33180866
[TBL] [Abstract][Full Text] [Related]
2. Ikaros dominant negative isoform (Ik6) induces IL-3-independent survival of murine pro-B lymphocytes by activating JAK-STAT and up-regulating Bcl-xl levels.
Kano G; Morimoto A; Takanashi M; Hibi S; Sugimoto T; Inaba T; Yagi T; Imashuku S
Leuk Lymphoma; 2008 May; 49(5):965-73. PubMed ID: 18464116
[TBL] [Abstract][Full Text] [Related]
3. Antagonism of B cell enhancer networks by STAT5 drives leukemia and poor patient survival.
Katerndahl CDS; Heltemes-Harris LM; Willette MJL; Henzler CM; Frietze S; Yang R; Schjerven H; Silverstein KAT; Ramsey LB; Hubbard G; Wells AD; Kuiper RP; Scheijen B; van Leeuwen FN; Müschen M; Kornblau SM; Farrar MA
Nat Immunol; 2017 Jun; 18(6):694-704. PubMed ID: 28369050
[TBL] [Abstract][Full Text] [Related]
4. Sleeping Beauty transposon screen identifies signaling modules that cooperate with STAT5 activation to induce B-cell acute lymphoblastic leukemia.
Heltemes-Harris LM; Larson JD; Starr TK; Hubbard GK; Sarver AL; Largaespada DA; Farrar MA
Oncogene; 2016 Jun; 35(26):3454-64. PubMed ID: 26500062
[TBL] [Abstract][Full Text] [Related]
5. Superenhancer reprogramming drives a B-cell-epithelial transition and high-risk leukemia.
Hu Y; Zhang Z; Kashiwagi M; Yoshida T; Joshi I; Jena N; Somasundaram R; Emmanuel AO; Sigvardsson M; Fitamant J; El-Bardeesy N; Gounari F; Van Etten RA; Georgopoulos K
Genes Dev; 2016 Sep; 30(17):1971-90. PubMed ID: 27664237
[TBL] [Abstract][Full Text] [Related]
6. Stage-specific control of early B cell development by the transcription factor Ikaros.
Schwickert TA; Tagoh H; Gültekin S; Dakic A; Axelsson E; Minnich M; Ebert A; Werner B; Roth M; Cimmino L; Dickins RA; Zuber J; Jaritz M; Busslinger M
Nat Immunol; 2014 Mar; 15(3):283-93. PubMed ID: 24509509
[TBL] [Abstract][Full Text] [Related]
7. Genome-wide identification of Ikaros targets elucidates its contribution to mouse B-cell lineage specification and pre-B-cell differentiation.
Ferreirós-Vidal I; Carroll T; Taylor B; Terry A; Liang Z; Bruno L; Dharmalingam G; Khadayate S; Cobb BS; Smale ST; Spivakov M; Srivastava P; Petretto E; Fisher AG; Merkenschlager M
Blood; 2013 Mar; 121(10):1769-82. PubMed ID: 23303821
[TBL] [Abstract][Full Text] [Related]
8. Genetic analysis of Ikaros target genes and tumor suppressor function in BCR-ABL1
Schjerven H; Ayongaba EF; Aghajanirefah A; McLaughlin J; Cheng D; Geng H; Boyd JR; Eggesbø LM; Lindeman I; Heath JL; Park E; Witte ON; Smale ST; Frietze S; Müschen M
J Exp Med; 2017 Mar; 214(3):793-814. PubMed ID: 28190001
[TBL] [Abstract][Full Text] [Related]
9. Dual Roles for Ikaros in Regulation of Macrophage Chromatin State and Inflammatory Gene Expression.
Oh KS; Gottschalk RA; Lounsbury NW; Sun J; Dorrington MG; Baek S; Sun G; Wang Z; Krauss KS; Milner JD; Dutta B; Hager GL; Sung MH; Fraser IDC
J Immunol; 2018 Jul; 201(2):757-771. PubMed ID: 29898962
[TBL] [Abstract][Full Text] [Related]
10. Ikaros regulation of the BCL6/BACH2 axis and its clinical relevance in acute lymphoblastic leukemia.
Ge Z; Zhou X; Gu Y; Han Q; Li J; Chen B; Ge Q; Dovat E; Payne JL; Sun T; Song C; Dovat S
Oncotarget; 2017 Jan; 8(5):8022-8034. PubMed ID: 28030830
[TBL] [Abstract][Full Text] [Related]
11. Transcriptional Regulation of PIK3CD and PIKFYVE in T-Cell Acute Lymphoblastic Leukemia by IKAROS and Protein Kinase CK2.
Dovat E; Song C; Hu T; Rahman MA; Dhanyamraju PK; Klink M; Bogush D; Soliman M; Kane S; McGrath M; Ding Y; Desai D; Sharma A; Gowda C
Int J Mol Sci; 2021 Jan; 22(2):. PubMed ID: 33467550
[TBL] [Abstract][Full Text] [Related]
12. Ikaros and Aiolos inhibit pre-B-cell proliferation by directly suppressing c-Myc expression.
Ma S; Pathak S; Mandal M; Trinh L; Clark MR; Lu R
Mol Cell Biol; 2010 Sep; 30(17):4149-58. PubMed ID: 20566697
[TBL] [Abstract][Full Text] [Related]
13. Transcriptional circuits in B cell transformation.
Hu Y; Yoshida T; Georgopoulos K
Curr Opin Hematol; 2017 Jul; 24(4):345-352. PubMed ID: 28463873
[TBL] [Abstract][Full Text] [Related]
14. BCR-ABL1 lymphoblastic leukaemia is characterized by the deletion of Ikaros.
Mullighan CG; Miller CB; Radtke I; Phillips LA; Dalton J; Ma J; White D; Hughes TP; Le Beau MM; Pui CH; Relling MV; Shurtleff SA; Downing JR
Nature; 2008 May; 453(7191):110-4. PubMed ID: 18408710
[TBL] [Abstract][Full Text] [Related]
15. BLNK suppresses pre-B-cell leukemogenesis through inhibition of JAK3.
Nakayama J; Yamamoto M; Hayashi K; Satoh H; Bundo K; Kubo M; Goitsuka R; Farrar MA; Kitamura D
Blood; 2009 Feb; 113(7):1483-92. PubMed ID: 19047679
[TBL] [Abstract][Full Text] [Related]
16. Deletions of the transcription factor Ikaros in myeloproliferative neoplasms.
Jäger R; Gisslinger H; Passamonti F; Rumi E; Berg T; Gisslinger B; Pietra D; Harutyunyan A; Klampfl T; Olcaydu D; Cazzola M; Kralovics R
Leukemia; 2010 Jul; 24(7):1290-8. PubMed ID: 20508609
[TBL] [Abstract][Full Text] [Related]
17. Tyrosyl phosphorylation and DNA binding activity of signal transducers and activators of transcription (STAT) proteins in hematopoietic cell lines transformed by Bcr/Abl.
Carlesso N; Frank DA; Griffin JD
J Exp Med; 1996 Mar; 183(3):811-20. PubMed ID: 8642285
[TBL] [Abstract][Full Text] [Related]
18. Non-DNA-binding Ikaros isoform gene expressed in adult B-precursor acute lymphoblastic leukemia.
Nishii K; Katayama N; Miwa H; Shikami M; Usui E; Masuya M; Araki H; Lorenzo F; Ogawa T; Kyo T; Nasu K; Shiku H; Kita K
Leukemia; 2002 Jul; 16(7):1285-92. PubMed ID: 12094252
[TBL] [Abstract][Full Text] [Related]
19. Reciprocal occupancy of BCL6 and STAT5 on Growth Hormone target genes: contrasting transcriptional outcomes and promoter-specific roles of p300 and HDAC3.
Lin G; LaPensee CR; Qin ZS; Schwartz J
Mol Cell Endocrinol; 2014 Sep; 395(1-2):19-31. PubMed ID: 25088465
[TBL] [Abstract][Full Text] [Related]
20. Loss of Ikaros DNA-binding function confers integrin-dependent survival on pre-B cells and progression to acute lymphoblastic leukemia.
Joshi I; Yoshida T; Jena N; Qi X; Zhang J; Van Etten RA; Georgopoulos K
Nat Immunol; 2014 Mar; 15(3):294-304. PubMed ID: 24509510
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
